We are studying a new treatment combining PXS-5505 and 5-Azacitidine for patients with MDS and CMML. The goal is to evaluate its safety and effectiveness compared to standard therapies.
Health conditions and diseases that the clinical trial is designed to study and treat.
Myelodysplastic Neoplasms (MDS) and Chronic Myelomonocytic Leukemia (CMML) are blood disorders that affect the bone marrow and blood cell production, leading to symptoms such as fatigue, weakness, and increased risk of infections.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.